A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)

Clinical trial NCT01090167 · COMPLETED

Trial details

NCT number: NCT01090167
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2010-02-01
Primary completion: 2011-04-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.